News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Acurian, Inc. Announces Licensing Agreement with i3 (Ann Arbor, Michigan) for Clinical Research Site Selection Services



11/19/2009 10:45:31 AM

HORSHAM, Pa.--(BUSINESS WIRE)--Acurian, Inc., a leading, full-service provider of patient recruitment and retention solutions, announced today that it entered into an agreement with pharmaceutical services company i3 to offer improved site identification and selection to its customers. Through the agreement, Acurian will provide site selection support to trial sponsors via i3’s services that offer statistics for improved planning and identification of trial sites with the most patients.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES